Cost of revenue increased 27.3%
Cost of revenue changed +27.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cost of revenue changed +27.3% from the comparable as-filed period.
Capital expenditure changed +749.8% from the comparable as-filed period.
Operating income changed +357.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Free-cash-flow margin changed +882 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1212 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +105.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow changed +175.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Current liabilities changed +13.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed +17.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed +146 basis points from the comparable as-filed period.
Inventory changed +1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Receivables / revenue changed +8 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.